Throat cancer is a relatively common type of head and neck malignancy with a high clinical incidence. Most patients require surgical treatment, and some need comprehensive treatment combining radiotherapy and chemotherapy. Generally, patients diagnosed in the early stages have better treatment outcomes and higher five-year survival rates. Typically, achieving a five-year survival rate after standardized surgery or radiotherapy and chemotherapy is considered a clinical cure. However, the proportion of patients in the middle to late stages achieving this is relatively low. Therefore, regular follow-ups are necessary to monitor the recovery process, regardless of the stage or type of the disease.